R3 Vascular Appoints Lisa Wipperman Heine to its Board of Directors

R3 Vascular Inc., a medical device company developing bioresorbable scaffolds for peripheral arterial disease treatment, announced the appointment of Lisa Wipperman Heine to its Board of Directors. Heine brings over 30 years of medical technology industry experience, including previous CEO roles and board positions at multiple medical device companies. The appointment comes as R3 Vascular accelerates clinical trials and prepares for commercialization of its MAGNITUDE® technology platform.